Synthego

Synthego Corporation is a biotechnology company specializing in genome engineering solutions, particularly using CRISPR technology. They generate revenue by providing high-quality synthetic RNA kits, genome editing tools, and bioinformatics software to research institutions and pharmaceutical companies. Founded in 2012 by brothers Paul and Michael Dabrowski, Synthego has rapidly grown due to its innovative approaches and partnerships with leading scientific organizations. Their mission is to accelerate the pace of scientific discovery and therapeutic development through precise and accessible genome engineering.

Recent Posts by Synthego

1-17 of 17